Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]

Domo (NASDAQ:DOMO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Domo Charts.

Domo (NASDAQ:DOMO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Domo Charts.

Domo Inc News

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
Tuesday 31 December 2024 (4 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 23 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 23 December 2024 (2 weeks ago) • Edgar (US Regulatory)

Domo Releases 12th Annual “Data Never Sleeps” Report
Wednesday 18 December 2024 (2 weeks ago) • Business Wire

Domo Wins KMWorld 2024 Readers' Choice Award for Best AI
Thursday 12 December 2024 (3 weeks ago) • Business Wire

Domo Partners with Richey May to Provide Powerful Data, Analytics and Actionable Insights to Mortgage Brokers
Tuesday 10 December 2024 (4 weeks ago) • Business Wire

Form 8-K - Current report
Thursday 5 December 2024 (1 month ago) • Edgar (US Regulatory)

Domo Announces Third Quarter Fiscal 2025 Financial Results
Thursday 5 December 2024 (1 month ago) • Business Wire

Domo Ranked #1 Vendor in Dresner Advisory Services’ 2024 Analytical Platforms Report
Tuesday 3 December 2024 (1 month ago) • Business Wire

Domo Named a Leader in the Nucleus Research 2024 Embedded Analytics Technology Value Matrix
Monday 2 December 2024 (1 month ago) • Business Wire

Domo to Host Virtual Event on the Power of AI Agents with Domo
Monday 2 December 2024 (1 month ago) • Business Wire

Domo Announces Timing of its Third Quarter Fiscal 2025 Earnings Conference Call
Thursday 21 November 2024 (1 month ago) • Business Wire

More Domo Inc News Articles

Anavex Life Sciences

Global Developments (PK)

Rennova Health (CE)

Fannie Mae (QB)

Elite Pharmaceuticals (QB)

Lightwave Logic

Northwest Biotherapeutics (QB)

Bioelectronics (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions